U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
You searched 8+ million full text articles

Try this search in 34+ million citations and abstracts

PMC Full-Text Search Results

Items: 1 to 20 of 1642

1.
Treatment of Insomnia with Zaleplon in HIV+ Significantly Improves Sleep and Depression
Jennifer R. Goldschmied, Arjun Sengupta, Anup Sharma, Lynne Taylor, Knashawn H. Morales, Michael E. Thase, Michael E. Thase, Aalim Weljie, Matthew S. Kayser
Psychopharmacol Bull. 2021 Jun 1; 51(3): 50–64.
PMCID:
PMC8374930
ArticlePDF–522K
2.
Polymeric nanoencapsulation of zaleplon into PLGA nanoparticles for enhanced pharmacokinetics and pharmacological activity
Yusuf A. Haggag, Ahmed Kh. Abosalha, Murtaza M. Tambuwala, Enass Y. Osman, Sanaa A. El‐Gizawy, Ebtessam A. Essa, Ahmed A. Donia
Biopharm Drug Dispos. 2021 Jan; 42(1): 12–23. Published online 2021 Jan 2. doi: 10.1002/bdd.2255
PMCID:
PMC7898708
ArticlePDF–1.1M
3.
Zaleplon and Zolpidem Objectively Alleviate Sleep Disturbances in Mountaineers at a 3,613 Meter Altitude
Maurice Beaumont, Denise Batéjat, Christophe Piérard, Pascal Van Beers, Matthieu Philippe, Damien Léger, Gustave Savourey, Jean-Claude Jouanin
Sleep. 2007 Nov 1; 30(11): 1527–1533. doi: 10.1093/sleep/30.11.1527
PMCID:
PMC2082097
ArticlePDF–396K
4.
A Visual ERP Study of Impulse Inhibition following a Zaleplon-Induced Nap after Sleep Deprivation
Qianru Zhang, Yang Liao, Jianlin Qi, Yongqi Zhao, Tianli Zhu, Zhaohui Liu, Xufeng Liu
PLoS One. 2014; 9(5): e95653. Published online 2014 May 7. doi: 10.1371/journal.pone.0095653
PMCID:
PMC4012989
ArticlePDF–400K
5.
Development and Characterization of Zaleplon Solid Dispersion Systems: A Technical Note
Atish Waghmare, Yogesh Pore, Bhanudas Kuchekar
AAPS PharmSciTech. 2008 Jun; 9(2): 536–543. Published online 2008 Apr 9. doi: 10.1208/s12249-008-9077-1
PMCID:
PMC2976925
ArticlePDF–289K
6.
Impact of Zaleplon on Continuous Positive Airway Pressure Therapy Compliance
John G. Park, Eric J. Olson, Timothy I. Morgenthaler
J Clin Sleep Med. 2013 May 15; 9(5): 439–444. Published online 2013 May 15. doi: 10.5664/jcsm.2660
PMCID:
PMC3629317
ArticlePDF–271K
7.
Meta-Analyses of Hypnotics and Infections: Eszopiclone, Ramelteon, Zaleplon, and Zolpidem
Florendo L. Joya, Daniel F. Kripke, Richard T. Loving, Arthur Dawson, Lawrence E. Kline
J Clin Sleep Med. 2009 Aug 15; 5(4): 377–383.
PMCID:
PMC2725260
ArticlePDF–1.2M
8.
Noise-induced sleep maintenance insomnia: hypnotic and residual effects of zaleplon
Barbara M Stone, Claire Turner, Sue L Mills, Isabelle Paty, Alain Patat, Mona Darwish, Philippe Danjou
Br J Clin Pharmacol. 2002 Feb; 53(2): 196–202. doi: 10.1046/j.-5251.2001.01520.x
PMCID:
PMC1874295
ArticlePDF–80K
9.
Rapid oral transmucosal delivery of zaleplon–lavender oil utilizing self-nanoemulsifying lyophilized tablets technology: development, optimization and pharmacokinetic evaluation
Sarah A. Ali, Nabil A. Alhakamy, Khaled M. Hosny, Eman Alfayez, Deena M. Bukhary, Awaji Y. Safhi, Moutaz Y. Badr, Rayan Y. Mushtaq, Majed Alharbi, Bader Huwaimel, Mohammed Alissa, Sameer Alshehri, Ali H. Alamri, Taha Alqahtani
Drug Deliv. 2022; 29(1): 2773–2783. Published online 2022 Aug 28. doi: 10.1080/10717544.2022.2115165
PMCID:
PMC9429977
ArticlePDF–1.2M
10.
Enhancement of zaleplon oral bioavailability using optimized self-nano emulsifying drug delivery systems and its effect on sleep quality among a sample of psychiatric patients
Maha K. A. Khalifa, Hoda A. Salem, Seham M. Shawky, Heba A. Eassa, Asmaa M. Elaidy
Drug Deliv. 2019; 26(1): 1243–1253. Published online 2019 Nov 21. doi: 10.1080/10717544.2019.1687613
PMCID:
PMC6882476
ArticlePDF–1.3M
11.
Zaleplon (Sonata) Oral Sedation for Outpatient Third Molar Extraction Surgery
Steven I Ganzberg, Thomas Dietrich, Manuel Valerin, F. Michael Beck
Anesth Prog. 2005 Winter; 52(4): 128–131. doi: 10.2344/0003-3006(2005)52[128:ZOS]2.0.CO;2
PMCID:
PMC1586798
ArticlePDF–83K
12.
An Insight into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions
Fabrizio Schifano, Stefania Chiappini, John M Corkery, Amira Guirguis
Int J Neuropsychopharmacol. 2019 Apr; 22(4): 270–277. Published online 2019 Feb 5. doi: 10.1093/ijnp/pyz007
PMCID:
PMC6441128
ArticlePDF–135K
13.
Allosteric Modulation of GABAA Receptor Subtypes: Effects on Visual Recognition and Visuospatial Working Memory in Rhesus Monkeys
Paul L Soto, Nancy A Ator, Sundari K Rallapalli, Poonam Biawat, Terry Clayton, James M Cook, Michael R Weed
Neuropsychopharmacology. 2013 Oct; 38(11): 2315–2325. Prepublished online 2013 May 31. Published online 2013 Jun 26. doi: 10.1038/npp.2013.137
Correction in:
Neuropsychopharmacology. 2013 Nov; 38(12): 2553.
PMCID:
PMC3773684
ArticlePDF–658K
14.
Cognition-Impairing Effects of Benzodiazepine-Type Drugs: Role of GABAA Receptor Subtypes in an Executive Function Task in Rhesus Monkeys
Leah Makaron, Casey A. Moran, Ojas Namjoshi, Sundari Rallapalli, James M. Cook, James K. Rowlett
Pharmacol Biochem Behav. Author manuscript; available in PMC 2014 Apr 7.
Published in final edited form as: Pharmacol Biochem Behav. 2013 Mar; 104: 62–68. Published online 2013 Jan 2. doi: 10.1016/j.pbb.2012.12.018
PMCID:
PMC3977599
ArticlePDF–1.1M
15.
Time Course of Aldehyde Oxidase and Why It Is Nonlinear
Armina Abbasi, Erickson M. Paragas, Carolyn A. Joswig-Jones, John T. Rodgers, Jeffrey P. Jones
Drug Metab Dispos. 2019 May; 47(5): 473–483. Published online 2019 May. doi: 10.1124/dmd.118.085787
PMCID:
PMC6439458
ArticlePDF–1.3M
16.
Use of short-acting and long-acting hypnotics and the risk of fracture: a critical analysis of associations in a nationwide cohort
P. Nordström, A. Nordström
Osteoporos Int. 2019; 30(10): 1983–1993. Published online 2019 Jul 30. doi: 10.1007/s00198-019-05085-5
PMCID:
PMC6795622
ArticlePDF–669K
17.
Occurrence of Z-drugs, benzodiazepines, and ketamine in wastewater in the United States and Mexico during the Covid-19 pandemic
Sangeet Adhikari, Rahul Kumar, Erin M. Driver, Devin A. Bowes, Keng Tiong Ng, Juan Eduardo Sosa-Hernandez, Mariel Araceli Oyervides-Muñoz, Elda M. Melchor-Martínez, Manuel Martínez-Ruiz, Karina G. Coronado-Apodaca, Ted Smith, Aruni Bhatnagar, Brian J. Piper, Kenneth L. McCall, Roberto Parra-Saldivar, Leon P. Barron, Rolf U. Halden
Sci Total Environ. 2023 Jan 20; 857: 159351. Published online 2022 Oct 12. doi: 10.1016/j.scitotenv.2022.159351
PMCID:
PMC9595400
ArticlePDF–1.1M
18.
The Clinical and Forensic Toxicology of Z-drugs
Naren Gunja
J Med Toxicol. 2013 Jun; 9(2): 155–162. Published online 2013 Feb 13. doi: 10.1007/s13181-013-0292-0
PMCID:
PMC3657020
ArticlePDF–183K
19.
In the Zzz Zone: The Effects of Z-Drugs on Human Performance and Driving
Naren Gunja
J Med Toxicol. 2013 Jun; 9(2): 163–171. Published online 2013 Mar 2. doi: 10.1007/s13181-013-0294-y
PMCID:
PMC3657033
ArticlePDF–183K
20.
Adverse effects of Z-drugs for sleep disturbance in people living with dementia: a population-based cohort study
Kathryn Richardson, Yoon K. Loke, Chris Fox, Ian Maidment, Robert Howard, Nicholas Steel, Antony Arthur, Penelope J. Boyd, Clare Aldus, Clive Ballard, George M. Savva
BMC Med. 2020; 18: 351. Published online 2020 Nov 24. doi: 10.1186/s12916-020-01821-5
PMCID:
PMC7683259
ArticlePDF–642K

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Search details

See more...

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center